Join the 200th Anniversary Celebration

Original Article

Birth Weight in Relation to Morbidity and Mortality among Newborn Infants

Donald D. McIntire, Ph.D., Steven L. Bloom, M.D., Brian M. Casey, M.D., and Kenneth J. Leveno, M.D.

N Engl J Med 1999; 340:1234-1238April 22, 1999

Abstract

Background

At any given gestational age, infants with low birth weight have relatively high morbidity and mortality. It is not known, however, whether there is a threshold weight below which morbidity and mortality are significantly greater, or whether that threshold varies with gestational age.

Methods

We analyzed the neonatal outcomes of death, five-minute Apgar score, umbilical-artery blood pH, and morbidity due to prematurity for all singleton infants delivered at Parkland Hospital, Dallas, between January 1, 1988, and August 31, 1996. A distribution of birth weights according to week of gestation at birth was created. Infants in the 26th through 75th percentiles for weight served as the reference group. Data on preterm infants (those born at 24 to 36 weeks of gestation) were analyzed separately from data on infants delivered at term (37 or more weeks of gestation).

Results

A total of 122,754 women and adolescents delivered singleton live infants without malformations between 24 and 43 weeks of gestation. Among the 12,317 preterm infants who were analyzed, there was no specific birth-weight percentile at which morbidity and mortality increased. Among 82,361 infants who were born at term and whose birth weights were at or below the 75th percentile, however, the rate of neonatal death increased from 0.03 percent in the reference group (26th through 75th percentile for weight) to 0.3 percent for those with birth weights at or below the 3rd percentile (P<0.001). The incidence of five-minute Apgar scores of 3 or less and umbilical-artery blood pH values of 7.0 or less was approximately doubled for infants at or below the 3rd birth-weight percentile (P=0.003 and P<0.001, respectively). The incidence of intubation at birth, seizures during the first day of life, and sepsis was also significantly increased among term infants with birth weights at or below the 3rd percentile. These differences persisted after adjustment for the mother's race and parity and the infant's sex.

Conclusions

Mortality and morbidity are increased among infants born at term whose birth weights are at or below the 3rd percentile for their gestational age.

Media in This Article

Figure 1Incidence of Respiratory Distress and Neonatal Death among 12,317 Preterm Infants (Born at 24 to 36 Weeks of Gestation), According to Birth-Weight Percentile.
Figure 2Incidence of Respiratory Distress among 12,317 Preterm Infants, According to Birth-Weight Percentile after Stratification According to Gestational Age (28 through 30 Weeks, 31 or 32 Weeks, 33 or 34 Weeks, and 35 or 36 Weeks).
Article

Each year in the United States, approximately 250,000 infants are born weighing less than 2500 g. These infants are classified as having low birth weight.1 Although the majority of these infants are born before term, approximately 40,000 are born at term according to National Institutes of Health estimates, having suffered intrauterine growth retardation.2

In 1963 Lubchenco and coworkers3 published detailed birth-weight nomograms according to gestational week. Small-for-gestational-age infants were subsequently defined as those whose weights were below the 10th percentile for their gestational ages.4 These infants were found to be at increased risk for neonatal death. For example, the neonatal mortality rate for small-for-gestational-age infants born at 38 weeks of gestation was 1 percent, as compared with 0.2 percent for those with appropriate birth weights. Not all infants with birth weights below the 10th percentile have pathologic growth retardation, however; some are small simply because of maternal constitutional factors.5,6

Although the concept of abnormal fetal growth is basic to modern ideas of perinatal medicine, there is limited information concerning the birth-weight threshold for a given gestational age at which morbidity and mortality increase significantly. For example some advocate the use of the 10th percentile as such a threshold value,4 whereas others recommend the 5th,7 3rd,8 or 15th9 percentile. We undertook this study to determine the birth-weight thresholds, for both preterm and term infants, associated with a significant increase in adverse neonatal outcomes. The birth-weight distribution used was specific to the study population. Between 1988 and 1996, approximately 127,000 infants were delivered at our hospital. The availability of data from this cohort permitted us to derive a population-based birth-weight nomogram and then to assess the birth-weight thresholds at which the well-being of newborn infants might be compromised.

Methods

Study Population

Selected obstetrical and neonatal outcomes for all women delivering infants at Parkland Hospital in Dallas are routinely entered into a computerized data base. Nurses attending each delivery complete an obstetrical data sheet, and research nurses assess the data for consistency and completeness before electronic storage. Data on infants' outcomes are abstracted from discharge records. Parkland Hospital is a tax-supported institution serving Dallas County. The obstetrics service is staffed by house officers and faculty members of the Department of Obstetrics and Gynecology at the University of Texas Southwestern Medical School.

Between January 1, 1988, and August 31, 1996, a total of 126,680 women and adolescents delivered infants at the hospital, of whom 122,754 were live-born singleton infants without malformations and with gestational ages of 24 weeks or more. Infants delivered at less than 24 weeks of gestational age were excluded from our study because their intrapartum management was influenced by concern about viability. Stillbirths were excluded because the gestational age at which fetal growth ceased could not be precisely determined, since delivery, and thus measurement of birth weight, often occurred days to weeks after fetal death. Ninety-seven percent of the mothers received prenatal care, averaging eight visits, in our hospital system. Approximately 60 percent were enrolled for prenatal care in the first trimester, and 90 percent enrolled before the end of the second trimester.

Gestational Age

For the purpose of this study, the obstetrical estimate of gestational age that was used to manage the care of the women and adolescents during the intrapartum period was also used to create a distribution of birth weights for each gestational week. This estimate was based on the date of the last menstrual period and the results of obstetrical ultrasonography, if any, performed during the pregnancy. The reported time of the last menstrual period was accepted as correct if the fundal height measured between 18 and 30 weeks of gestation was correlated with the week of gestation within 2 cm.10 Subjects with discrepancies between the two values underwent obstetrical ultrasonography.

The validity of the obstetrical estimate of gestational age based on the menstrual history was assessed by two separate methods. First, a cohort of 34,475 women and adolescents who underwent antepartum ultrasonography was identified. These subjects did not differ significantly from the total study population with regard to age, race, or parity. The correlation coefficient for the estimate of gestational age based on ultrasonography and the obstetrical estimate of gestational age based on the last menstrual period was 0.9. The mean (±SD) gestational age at the time of ultrasonography was 25±7 weeks. Similarly, the correlation coefficient for the obstetrical estimate of gestational age and the pediatrician's assessment of the gestational age of the newborn infant was 0.7. In 108,493 women (88 percent), the obstetrical estimate and the pediatrician's estimate were within two weeks of each other. (The obstetrical estimates of gestational age were available to the pediatricians.)

Birth Weight

The distributions of birth weights for each completed week of gestation were examined for statistical normality, and smoothed birth-weight curves were derived for each percentile.11 For example, 38 completed weeks of gestation included 38 weeks, 0 days, through 38 weeks, 6 days. Six categories of birth-weight percentile were selected for study: the 3rd or below, 4th through 5th, 6th through 10th, 11th through 15th, 16th through 25th, and 26th through 75th percentiles. Infants whose birth weights fell in the 26th through 75th percentiles were used as the reference group.

Outcome Measures

The outcomes we studied included death up to 28 days of age, an Apgar score of 3 or less at five minutes, and an umbilical-artery blood pH of 7.0 or less. The latter two measurements assessed characteristics attributable to the condition of the infant at birth. Umbilical-cord blood was obtained from all infants for measurement of pH. In infants born at term, morbidity was defined as the onset of seizures in the first 24 hours after birth or the need for intubation in the delivery room. In preterm infants, morbidity was defined as respiratory distress (the need for ventilator therapy in the first 24 hours after birth); intraventricular hemorrhage, grade 3 or 4; necrotizing enterocolitis requiring surgery; or sepsis. The diagnosis of sepsis required a positive blood culture.

Statistical Analysis

Smoothed curves for birth-weight percentiles according to gestational age were derived for the entire cohort. Similar curves were also constructed according to the mother's race and parity and the infant's sex. Univariate analysis of infants' outcomes according to birth-weight percentile was performed with use of chi-square statistics. The estimates and significance levels were adjusted for the mother's race and parity and the infant's sex by the Cochran–Mantel–Haenszel method. Bonferroni corrections were used in cases of multiple testing. All P values are two-sided.

Results

Of the women and adolescents whose pregnancy outcomes are described in this report, 54 percent (65,712) were Hispanic, 28 percent (34,872) were black, 15 percent (18,616) were white, and 3 percent (3554) were of other racial or ethnic backgrounds. The mean maternal age was 24±6 years; 3 percent were under the age of 16 years and 4 percent were 35 years old or older. A total of 45,937 (37 percent) were nulliparous.

Data on 122,754 singleton infants without malformations (12,317 preterm infants and 110,437 term infants) were available for analysis. Of these, 91,580 infants (9219 preterm infants and 82,361 term infants) had birth weights at or below the 75th percentile. The infants' outcomes, according to birth-weight percentile, were analyzed separately for those delivered at 36 weeks or less of gestation (preterm birth) and those delivered at 37 weeks or more (birth at term).

Preterm Infants

Selected outcomes for the 9219 preterm infants with birth weights at or below the 75th percentile are shown according to birth-weight category in Table 1Table 1Outcomes of Live-Born Singleton Preterm Infants (Born at 24 to 36 Weeks of Gestation) in Relation to Birth-Weight Percentile.. The presence or absence of severe fetal acidemia (umbilical-artery blood pH, 7.0 or less), necrotizing enterocolitis, and sepsis was not related to birth-weight category. The incidence of grade 3 or 4 intraventricular hemorrhage, however, was significantly increased among preterm infants in the smallest birth-weight category. Grade 3 or 4 intraventricular hemorrhage was diagnosed in 3.2 percent of infants at or below the 3rd percentile for birth weight, as compared with 1.5 percent in the reference group of infants in the 26th through 75th percentiles (P= 0.01). The incidence of respiratory distress requiring ventilator therapy was significantly increased among infants in each of the birth-weight percentiles below the 26th percentile, as compared with the reference group (Table 1).

Because the incidence of respiratory distress was significantly higher in all the birth-weight percentiles below the 26th percentile than in the reference group, we expanded the analysis to include all possible birth-weight percentiles (Figure 1Figure 1Incidence of Respiratory Distress and Neonatal Death among 12,317 Preterm Infants (Born at 24 to 36 Weeks of Gestation), According to Birth-Weight Percentile.). The incidence of respiratory distress increased as the birth-weight percentile decreased. Analysis of the data after stratification according to gestational-age groups revealed an increasing incidence of respiratory distress associated with both lower gestational age and lower birth-weight percentile (Figure 2Figure 2Incidence of Respiratory Distress among 12,317 Preterm Infants, According to Birth-Weight Percentile after Stratification According to Gestational Age (28 through 30 Weeks, 31 or 32 Weeks, 33 or 34 Weeks, and 35 or 36 Weeks).). As we did with respiratory distress, we expanded the analysis of neonatal death to encompass all birth-weight percentiles (Figure 1). Neonatal death rates among preterm infants were proportional to fetal weight across the entire spectrum of birth-weight percentiles. The birth-weight–percentile thresholds for a significantly increased risk of respiratory distress and neonatal death among preterm infants were also analyzed with adjustment for the mother's race and parity and the infant's sex. No specific birth-weight threshold was significantly associated with either of these outcomes.

Term Infants

Selected outcomes for 82,361 term infants in relation to their birth-weight percentiles are shown in Table 2Table 2Outcomes of Live-Born Singleton Term Infants (Born at ≥37 Weeks of Gestation) in Relation to Birth-Weight Percentile.. The analysis excluded 28,076 infants whose birth weights were above the 75th percentile. The percentage of infants with low five-minute Apgar scores was significantly higher among those at or below the 3rd birth-weight percentile (0.2 percent) than in the reference group (0.1 percent; P=0.003). Similarly, the incidence of severe fetal acidemia and the need for intubation in the delivery room was significantly higher among the infants in this group (P<0.001 for both outcomes). The incidence of seizures during the first 24 hours of life, a potential reflection of intrapartum stress, was significantly increased in two of the lowest birth-weight groups (those at or below the 3rd percentile, and those in the 6th through the 10th percentiles). The rates of incidence of sepsis and neonatal death were also significantly increased among infants at or below the 3rd percentile. In fact, the incidence of neonatal death was almost 10 times as high among infants with birth weights at or below the 3rd percentile as in the reference group (0.3 percent vs. 0.03 percent, P<0.001).

The data set was also analyzed with adjustment for the infant's sex and the mother's race. The 3rd-percentile birth-weight threshold for increased morbidity and mortality (Table 2) remained significant when the data were analyzed according to these demographic factors. Similarly, parity did not significantly influence the birth-weight thresholds for adverse neonatal outcomes.

Discussion

The threshold birth-weight percentile for infant mortality and for most indexes of morbidity that appears to define the boundary between normal and abnormal fetal growth is more readily apparent among term infants than among preterm infants. Morbidity and mortality were significantly higher among term infants who were at or below the 3rd percentile of weight for their gestational age. In contrast, there was no specific birth-weight threshold for neonatal morbidity or mortality among preterm infants. Indeed, the risk of adverse outcomes, such as respiratory distress and neonatal death, increased continuously with decreasing birth-weight percentiles among preterm infants.

There have been few reports describing birth-weight thresholds for adverse infant outcomes. The earliest such report4 linked neonatal death to birth weight at the 10th percentile. For more than 30 years, this percentile has been defined as the threshold for clinically important fetal growth restriction. Manning5 also defined the 10th percentile as the threshold for elevated neonatal morbidity and mortality, manifested as birth asphyxia and abnormal neurologic development. However, all infants with birth weights above the 10th percentile were considered to be of appropriate size for their gestational age. We chose to analyze our results with birth weights at the 26th through 75th percentiles as the norm for fetal growth. Larger infants were excluded because they may have morbidity associated with excessive size. Manning described a continuum of increasing risk for adverse infant outcomes as birth weight decreased from the 10th to the 1st percentile for gestational age. On the basis of an analysis of 8719 births, Kramer and colleagues12 also concluded that morbidity and mortality were continuously and inversely proportional to fetal growth. Neonatal outcomes related to suboptimal fetal growth are associated with adverse neurologic outcomes at two years of age.13

There have been several reports of accelerated fetal pulmonary maturation in association with intrauterine growth restriction, defined as a birth weight for gestational age that is below the 10th percentile. One explanation for this phenomenon is that the fetus responds to a stressful environment by increasing adrenal glucocorticoid production, which leads to accelerated fetal lung maturation.14 Although this concept pervades modern thinking about perinatal medicine, there is considerable controversy as to whether the growth-restricted infant truly has an advantage with respect to the risk of respiratory distress. The results of our analysis of preterm infants, along with other recent reports,15 challenge this concept of accelerated maturation. We could not identify a specific fetal-growth threshold for respiratory disease; instead, we found that the incidence of respiratory distress was inversely proportional to the birth-weight percentile. However, respiratory distress was also significantly associated with gestational age among preterm infants. We therefore analyzed the incidence of respiratory distress at all birth-weight percentiles in relation to gestational age; the incidence of respiratory disease was directly related to both the birth-weight percentile and gestational age. In other words, morbidity among preterm infants is influenced by both fetal growth and fetal age. The same relations were not found among term infants, in whom the effects of suboptimal fetal growth appear to be limited to the most severely undergrown infants. The effects of suboptimal fetal growth persisted after adjustment for the mother's race and parity and the infant's sex.

When is fetal growth suboptimal, or how small is too small? Our results suggest that for term infants, the answer is the 3rd birth-weight percentile. For preterm infants, the effects of suboptimal fetal growth are intensified by immaturity, making it difficult to discern a fetal-growth threshold that clearly identifies growth-restricted infants who are at increased risk for illness and death.

Source Information

From the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas.

Address reprint requests to Dr. McIntire at the Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9032, or at .

References

References

  1. 1

    Fetal growth restriction. In: Cunningham FG, MacDonald PC, Gant NF, et al. Williams obstetrics. 20th ed. Stamford, Conn.: Appleton & Lange, 1997:839-51.

  2. 2

    National Institutes of Health. Diagnostic ultrasound imaging in pregnancy. Washington, D.C.: Government Printing Office, 1984. (NIH publication no. 84-667.)

  3. 3

    Lubchenco LO, Hansman C, Dressler M, Boyd E. Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800
    Web of Science | Medline

  4. 4

    Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159-163
    CrossRef | Web of Science | Medline

  5. 5

    Manning FA. Fetal medicine: principles and practice. Norwalk, Conn.: Appleton & Lange, 1995:317.

  6. 6

    Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992;339:283-287
    CrossRef | Web of Science | Medline

  7. 7

    Breart G, Rabarison Y, Plouin PF, Sureau C, Rumeau-Rouquette C. Risk of fetal growth retardation as a result of maternal hypertension: preparation to a trial on antihypertensive drugs. Dev Pharmacol Ther 1982;4:Suppl:116-123
    Medline

  8. 8

    Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969;74:901-910
    CrossRef | Web of Science | Medline

  9. 9

    Seeds JW, Peng T. Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 1998;178:658-669
    CrossRef | Web of Science | Medline

  10. 10

    Jimenez JM, Tyson JE, Reisch JS. Clinical measures of gestational age in normal pregnancies. Obstet Gynecol 1983;61:438-443
    Web of Science | Medline

  11. 11

    Velleman PF. Definition and comparison of robust nonlinear data smoothing algorithms. J Am Stat Assoc 1980;75:609-615
    CrossRef | Web of Science

  12. 12

    Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH. Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics 1990;86:707-713
    Web of Science | Medline

  13. 13

    Spinillo A, Capuzzo E, Egbe TO, Fazzi E, Colonna L, Nicola S. Pregnancies complicated by idiopathic intrauterine growth retardation: severity of growth failure, neonatal morbidity and two-year infant neurodevelopmental outcome. J Reprod Med 1995;40:209-215
    Web of Science | Medline

  14. 14

    Laatikainen TJ, Raisanen IJ, Salminen KR. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am J Obstet Gynecol 1988;159:891-895
    Web of Science | Medline

  15. 15

    Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants? Obstet Gynecol 1996;87:169-174
    CrossRef | Web of Science | Medline

Citing Articles (198)

Citing Articles

  1. 1

    Hien Q. Le, Stuart A. Batterman, Julia J. Wirth, Robert L. Wahl, Katherine J. Hoggatt, Alireza Sadeghnejad, Mary Lee Hultin, Michael Depa. (2012) Air pollutant exposure and preterm and term small-for-gestational-age births in Detroit, Michigan: Long-term trends and associations. Environment International
    CrossRef

  2. 2

    M. Margaret Weigel, Maria Elena Caiza Sanchez. (2012) Ethnic/Racial Disparities in the Fetal Growth Outcomes of Ecuadorian Newborns. Journal of Immigrant and Minority Health
    CrossRef

  3. 3

    C. A. Snijder, N. Roeleveld, E. te Velde, E. A. P. Steegers, H. Raat, A. Hofman, V. W. V. Jaddoe, A. Burdorf. (2012) Occupational exposure to chemicals and fetal growth: the Generation R Study. Human Reproduction
    CrossRef

  4. 4

    Rebecca Simmons. 2012. Abnormalities of Fetal Growth. , 51-59.
    CrossRef

  5. 5

    Tamara T. Chao, Steven L. Bloom, Judith S. Mitchell, Donald D. McIntire, Kenneth J. Leveno. (2011) The Diagnosis and Natural History of False Preterm Labor. Obstetrics & Gynecology 118:6, 1301-1308
    CrossRef

  6. 6

    AAAMJ Djelantik, AE Kunst, MF van der Wal, HA Smit, TGM Vrijkotte. (2011) Contribution of overweight and obesity to the occurrence of adverse pregnancy outcomes in a multi-ethnic cohort: population attributive fractions for Amsterdam. BJOG: An International Journal of Obstetrics & Gynaecologyno-no
    CrossRef

  7. 7

    Amy Chui, Nurul Zainuddin, Gayathri Rajaraman, Padma Murthi, Shaun P. Brennecke, Vera Ignjatovic, Paul T. Monagle, Joanne M. Said. (2011) Placental Syndecan Expression Is Altered in Human Idiopathic Fetal Growth Restriction. The American Journal of Pathology
    CrossRef

  8. 8

    Amy Chui, Charmaine Tay, Melanie Cocquebert, Penelope Sheehan, Niroshani A. Pathirage, Susan Donath, Thierry Fournier, Josette Badet, Daniele Evain-Brion, Shaun P. Brennecke, Bill Kalionis, Padma Murthi. (2011) Homeobox gene Distal-Less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction. Journal of Molecular Medicine
    CrossRef

  9. 9

    Mingming Su, Xiao Ying Zheng, Ting Zhang, Lijun Pei, Fang Wang, Xiaojiao Zheng, Xue Gu, Xinming Song, Xiaolin Lu, Gong Chen, Yihua Bao, Tianlu Chen, Aihua Zhao, Yuqian Bao, Wei Ping Jia, Steven H. Zeisel, Wei Jia. (2011) Integrated profiling of metabolites and trace elements reveals a multifaceted malnutrition in pregnant women from a region with a high prevalence of congenital malformations. Metabolomics
    CrossRef

  10. 10

    Keisuke Ishii, Mari Saito, Masahiko Nakata, Yuichiro Takahashi, Satoshi Hayashi, Takeshi Murakoshi, Jun Murotsuki, Hiroshi Kawamoto, Haruhiko Sago. (2011) Ultrasound prognostic factors after laser surgery for twin-twin transfusion syndrome to predict survival at 6 months. Prenatal Diagnosis 31:11, 1097-1100
    CrossRef

  11. 11

    Mariko Doi, Rokeya Sultana Rekha, Sultan Ahmed, Masafumi Okada, Anjan Kumar Roy, Shams El Arifeen, Eva-Charlotte Ekström, Rubhana Raqib, Yukiko Wagatsuma. (2011) Association between calcium in cord blood and newborn size in Bangladesh. British Journal of Nutrition 106:09, 1398-1407
    CrossRef

  12. 12

    Shane Reeves, Henry L. Galan. 2011. Fetal growth restriction. , 329-344.
    CrossRef

  13. 13

    Henry L. Galan. (2011) Timing Delivery of the Growth-Restricted Fetus. Seminars in Perinatology 35:5, 262-269
    CrossRef

  14. 14

    Vasilios Tsitouras, Spyros Sgouros. (2011) Infantile posthemorrhagic hydrocephalus. Child's Nervous System 27:10, 1595-1608
    CrossRef

  15. 15

    Nemanja Višnjevac, Ljiljana Mladenović Segedi, Aleksandar Ćurčić, Jovana Višnjevac, Dragan Stajić. (2011) Blood Ferritin Levels in Pregnant Women and Prediction of the Development of Fetal Intrauterine Growth Restriction. Journal of Medical Biochemistry 30:4, 317-322
    CrossRef

  16. 16

    IOANNIS PAPASTEFANOU, ATHENA P. SOUKA, ATHANASIOS PILALIS, MAKARIOS ELEFTHERIADES, VASILIKI MICHALITSI, DEMETRIOS KASSANOS. (2011) First trimester prediction of small- and large-for-gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics. Acta Obstetricia et Gynecologica Scandinavicano-no
    CrossRef

  17. 17

    L.A. Reyes-Castro, J.S. Rodriguez, R. Charco, C.J. Bautista, F. Larrea, P.W. Nathanielsz, E. Zambrano. (2011) Maternal protein restriction in the rat during pregnancy and/or lactation alters cognitive and anxiety behaviors of female offspring. International Journal of Developmental Neuroscience
    CrossRef

  18. 18

    Lisa A. Joss-Moore, Kurt H. Albertine, Robert H. Lane. (2011) Epigenetics and the developmental origins of lung disease. Molecular Genetics and Metabolism 104:1-2, 61-66
    CrossRef

  19. 19

    Kristen GIBBONS, Michael BECKMANN, Vicki FLENADY, Dominique ROSSOUW, Glenn GARDENER, Kassam MAHOMED, Peter H. GRAY, Paul DEVENISH-MEARES. (2011) A survey of policies for the monitoring of fetal growth in Australian and New Zealand hospitals. Australian and New Zealand Journal of Obstetrics and Gynaecologyno-no
    CrossRef

  20. 20

    Popi Sifianou, Vasso Ktena, Helen Karga. (2011) Diagnostic markers in combination improve the identification of growth-restricted neonates. Early Human Development 87:8, 549-554
    CrossRef

  21. 21

    &NA;. (2011) Decreased Term and Postterm Birthweight in the United States. Survey of Anesthesiology 55:4, 181
    CrossRef

  22. 22

    Bobby Paul, Indranil Saha, Abhijit Mukherjee, Ranadeb Biswas, Sima Roy, Ramendra N. Chaudhuri. (2011) Morbidity pattern of low-birth-weight infants in an urban slum of Kolkata, India. Journal of the Egyptian Public Health Association 86:3 and 4, 39-43
    CrossRef

  23. 23

    Sorina Grisaru-Granovsky, Brian Reichman, Liat Lerner-Geva, Valentina Boyko, Cathy Hammerman, Arnon Samueloff, Michael S. Schimmel. (2011) Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study. American Journal of Obstetrics and Gynecology
    CrossRef

  24. 24

    Mellisa DAMODARAM, Lisa STORY, Elena KULINSKAYA, Mary RUTHERFORD, Sailesh KUMAR. (2011) Early adverse perinatal complications in preterm growth-restricted fetuses. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:3, 204-209
    CrossRef

  25. 25

    Methodius G. Tuuli, Alison Cahill, David Stamilio, George Macones, Anthony O. Odibo. (2011) Comparative Efficiency of Measures of Early Fetal Growth Restriction for Predicting Adverse Perinatal Outcomes. Obstetrics & Gynecology 117:6, 1331-1340
    CrossRef

  26. 26

    Vicki Flenady, Philippa Middleton, Gordon C Smith, Wes Duke, Jan Jaap Erwich, T Yee Khong, Jim Neilson, Majid Ezzati, Laura Koopmans, David Ellwood, Ruth Fretts, J Frederik Frøen. (2011) Stillbirths: the way forward in high-income countries. The Lancet 377:9778, 1703-1717
    CrossRef

  27. 27

    Glyn D. Williams, Ronald S. Cohen. (2011) Perioperative management of low birth weight infants for open-heart surgery. Pediatric Anesthesia 21:5, 538-553
    CrossRef

  28. 28

    Bodil Hammer Bech. (2011) What advice should be given to pregnant mothers on caffeine consumption?. Expert Review of Obstetrics & Gynecology 6:3, 259-272
    CrossRef

  29. 29

    Yaron Haimovich, Jessica Ascher-Landsberg, Fuad Azem, Dror Mandel, Francis B. Mimouni, Ariel Many. (2011) Neonatal outcome of preterm discordant twins. Journal of Perinatal Medicine 39:3, 317-322
    CrossRef

  30. 30

    Maja Predojević, Milan Stanojević, Oliver Vasilj, Aida Salihagić Kadić. (2011) Prenatal and postnatal neurological evaluation of a fetus and newborn from pregnancy complicated with IUGR and fetal hypoxemia. Journal of Maternal-Fetal and Neonatal Medicine 24:5, 764-767
    CrossRef

  31. 31

    Samantha J. Lain, Charles S. Algert, Natasha Nassar, Jennifer R. Bowen, Christine L. Roberts. (2011) Incidence of Severe Adverse Neonatal Outcomes: Use of a Composite Indicator in a Population Cohort. Maternal and Child Health Journal
    CrossRef

  32. 32

    Vasileios Giapros, Aikaterini Drougia, Nikolaos Krallis, Paraskevi Theocharis, Styliani Andronikou. (2011) Morbidity and mortality patterns in small-for-gestational age infants born preterm. Journal of Maternal-Fetal and Neonatal Medicine1-5
    CrossRef

  33. 33

    Kimberly K. Vesco, Andrea J. Sharma, Patricia M. Dietz, Joanne H. Rizzo, William M. Callaghan, Lucinda England, F. Carol Bruce, Donald J. Bachman, Victor J. Stevens, Mark C. Hornbrook. (2011) Newborn Size Among Obese Women With Weight Gain Outside the 2009 Institute of Medicine Recommendation. Obstetrics & Gynecology 117:4, 812-818
    CrossRef

  34. 34

    Beth A. Bailey, Judy G. McCook, Alexis Hodge, Lana McGrady. (2011) Infant Birth Outcomes Among Substance Using Women: Why Quitting Smoking During Pregnancy is Just as Important as Quitting Illicit Drug Use. Maternal and Child Health Journal
    CrossRef

  35. 35

    B. Olav Asvold, L. J. Vatten, P. R. Romundstad, P. A. Jenum, S. A. Karumanchi, A. Eskild. (2011) Angiogenic Factors in Maternal Circulation and the Risk of Severe Fetal Growth Restriction. American Journal of Epidemiology 173:6, 630-639
    CrossRef

  36. 36

    J. Zhang, R. Mikolajczyk, J. Grewal, G. Neta, M. Klebanoff. (2011) Prenatal Application of the Individualized Fetal Growth Reference. American Journal of Epidemiology 173:5, 539-543
    CrossRef

  37. 37

    Methodius G. Tuuli, Anthony O. Odibo. (2011) The Role of Serum Markers and Uterine Artery Doppler in Identifying At-Risk Pregnancies. Clinics in Perinatology 38:1, 1-19
    CrossRef

  38. 38

    Loren N. Petrozella, Jodi S. Dashe, Donald D. McIntire, Kenneth J. Leveno. (2011) Clinical Significance of Borderline Amniotic Fluid Index and Oligohydramnios in Preterm Pregnancy. Obstetrics & Gynecology 117:2, Part 1, 338-342
    CrossRef

  39. 39

    R. K. Morris, G. Malin, S. C. Robson, J. Kleijnen, J. Zamora, K. S. Khan. (2011) Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high-risk population: systematic review and bivariate meta-analysis. Ultrasound in Obstetrics & Gynecology 37:2, 135-142
    CrossRef

  40. 40

    K. E. Boers, J. A. M. van der Post, Ben W. J. Mol, J. M. M. van Lith, S. A. Scherjon. (2011) Labour and Neonatal Outcome in Small for Gestational Age Babies Delivered Beyond 36+0 Weeks: A Retrospective Cohort Study. Journal of Pregnancy 2011, 1-5
    CrossRef

  41. 41

    Akimune Fukushima, Kenji Nakai, Tomonobu Kanasugi, Miyuki Terata, Toru Sugiyama. (2011) Assessment of Fetal Autonomic Nervous System Activity by Fetal Magnetocardiography: Comparison of Normal Pregnancy and Intrauterine Growth Restriction. Journal of Pregnancy 2011, 1-6
    CrossRef

  42. 42

    Mariam Moshiri, Sophia Rothberger. (2011) Fetal Growth Abnormalities. Ultrasound Clinics 6:1, 57-67
    CrossRef

  43. 43

    Jacqueline E. A. K. Bamfo, Anthony O. Odibo. (2011) Diagnosis and Management of Fetal Growth Restriction. Journal of Pregnancy 2011, 1-15
    CrossRef

  44. 44

    Padma Murthi, Gayathri Rajaraman, Shaun Patrick Brennecke, Bill Kalionis. (2011) The Role of Placental Homeobox Genes in Human Fetal Growth Restriction. Journal of Pregnancy 2011, 1-11
    CrossRef

  45. 45

    Riikka Turunen, Sture Andersson, Hannele Laivuori, Eero Kajantie, Sanna Siitonen, Heikki Repo, Irmeli Nupponen. (2011) Increased Postnatal Inflammation in Mechanically Ventilated Preterm Infants Born to Mothers with Early-Onset Preeclampsia. Neonatology 100:3, 241-247
    CrossRef

  46. 46

    K. Ishii, T. Murakoshi, S. Hayashi, M. Saito, H. Sago, Y. Takahashi, M. Sumie, M. Nakata, M. Matsushita, T. Shinno, H. Naruse, Y. Torii. (2011) Ultrasound predictors of mortality in monochorionic twins with selective intrauterine growth restriction. Ultrasound in Obstetrics & Gynecology 37:1, 22-26
    CrossRef

  47. 47

    Anna Alisi, Nadia Panera, Carlo Agostoni, Valerio Nobili. (2011) Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children. International Journal of Endocrinology 2011, 1-8
    CrossRef

  48. 48

    Soon Ju Kim, Il Hyun Cho, Yeon Soo Cho, Young Ah Youn, Ju Young Lee, Hyun Seung Lee, Jung Hyun Lee, In Kyung Sung, So Young Kim. (2011) Hematologic Characteristics of Intrauterine Growth Restricted Small for Gestational Age Infants. Journal of the Korean Society of Neonatology 18:2, 248
    CrossRef

  49. 49

    Stefan Savchev, Francesc Figueras, Rogelio Cruz Martinez, Miriam Illa, Francesc Botet, Eduard Gratacos. (2011) Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age fetuses with normal umbilical, brain and uterine Doppler. Ultrasound in Obstetrics & Gynecologyn/a-n/a
    CrossRef

  50. 50

    Jennifer Zeitlin, Mayass El Ayoubi, Pierre-Henri Jarreau, Elizabeth S. Draper, Béatrice Blondel, Wolfgang Künzel, Marina Cuttini, Monique Kaminski, Ludwig Gortner, Patrick Van Reempts, Louis Kollée, Emile Papiernik. (2010) Impact of Fetal Growth Restriction on Mortality and Morbidity in a Very Preterm Birth Cohort. The Journal of Pediatrics 157:5, 733-739.e1
    CrossRef

  51. 51

    Pavel Rossner, Nana Tabashidze, Miroslav Dostal, Zuzana Novakova, Irena Chvatalova, Milada Spatova, Radim J. Sram. (2010) Genetic, Biochemical, and Environmental Factors Associated with Pregnancy Outcomes in Newborns from the Czech Republic. Environmental Health Perspectives 119:2, 265-271
    CrossRef

  52. 52

    R.P. Horgan, D.I. Broadhurst, W.B. Dunn, M. Brown, A.E.P. Heazell, D.B. Kell, P.N. Baker, L.C. Kenny. (2010) Changes in the Metabolic Footprint of Placental Explant-Conditioned Medium Cultured in Different Oxygen Tensions from Placentas of Small for Gestational Age and Normal Pregnancies. Placenta 31:10, 893-901
    CrossRef

  53. 53

    Irene A. Stafford, Jodi S. Dashe, Stephan A. Shivvers, James M. Alexander, Donald D. McIntire, Kenneth J. Leveno. (2010) Ultrasonographic Cervical Length and Risk of Hemorrhage in Pregnancies With Placenta Previa. Obstetrics & Gynecology 116:3, 595-600
    CrossRef

  54. 54

    R. Katie Morris, Tara J. Selman, Meenakshi Verma, Stephen C. Robson, Jos Kleijnen, Khalid S. Khan. (2010) Systematic review and meta-analysis of the test accuracy of ductus venosus Doppler to predict compromise of fetal/neonatal wellbeing in high risk pregnancies with placental insufficiency. European Journal of Obstetrics & Gynecology and Reproductive Biology 152:1, 3-12
    CrossRef

  55. 55

    George Mitsiakos, Evaggelia Giougi, Ilias Chatziioannidis, Paraskevi Karagianni, Emmanouil Papadakis, Christos Tsakalidis, Georgia Papaioannou, Pavlos Malindretos, Nikolaos Nikolaidis. (2010) Haemostatic profile of healthy premature small for gestational age neonates. Thrombosis Research 126:2, 103-106
    CrossRef

  56. 56

    Yinguo Zhang, Ning Li, Jiajia Yang, Tao Zhang, Zhuo Yang. (2010) Effects of maternal food restriction on physical growth and neurobehavior in newborn Wistar rats. Brain Research Bulletin 83:1-2, 1-8
    CrossRef

  57. 57

    Tamara T. Chao, Jodi S. Dashe, Richard C. Adams, Amy Keefover-Hicks, Donald D. McIntire, Diane M. Twickler. (2010) Central Nervous System Findings on Fetal Magnetic Resonance Imaging and Outcomes in Children With Spina Bifida. Obstetrics & Gynecology 116:2, Part 1, 323-329
    CrossRef

  58. 58

    P. Vergani, N. Roncaglia, A. Ghidini, I. Crippa, I. Cameroni, F. Orsenigo, J. Pezzullo. (2010) Can adverse neonatal outcome be predicted in late preterm or term fetal growth restriction?. Ultrasound in Obstetrics and Gynecology 36:2, 166-170
    CrossRef

  59. 59

    Xun Zhang, K.S. Joseph, Michael S. Kramer. (2010) Decreased term and postterm birthweight in the United States: impact of labor induction. American Journal of Obstetrics and Gynecology 203:2, 124.e1-124.e7
    CrossRef

  60. 60

    Parul Christian. (2010) Micronutrients, Birth Weight, and Survival. Annual Review of Nutrition 30:1, 83-104
    CrossRef

  61. 61

    Ali S. Khashan, Louise C. Kenny, Roseanne McNamee, Preben B. Mortensen, Marianne G. Pedersen, Fergus P. McCarthy, Tine B. Henriksen. (2010) Undiagnosed coeliac disease in a father does not influence birthweight and preterm birth. Paediatric and Perinatal Epidemiology 24:4, 363-369
    CrossRef

  62. 62

    Bolajoko O. Olusanya. (2010) Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference. Early Human Development 86:7, 439-444
    CrossRef

  63. 63

    Jodie M Dodd, Anne McLeod, Rory C Windrim, John Kingdom, Jodie M Dodd. 2010. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. .
    CrossRef

  64. 64

    Jun Zhang, Mario Merialdi, Lawrence D. Platt, Michael S. Kramer. (2010) Defining normal and abnormal fetal growth: promises and challenges. American Journal of Obstetrics and Gynecology 202:6, 522-528
    CrossRef

  65. 65

    Hammad A. Ganatra, Barbara J. Stoll, Anita K.M. Zaidi. (2010) International Perspective on Early-Onset Neonatal Sepsis. Clinics in Perinatology 37:2, 501-523
    CrossRef

  66. 66

    Hiroko Watanabe, Kazuko Inoue, Masako Doi, Momoyo Matsumoto, Kayoko Ogasawara, Hideoki Fukuoka, Yasushi Nagai. (2010) Risk factors for term small for gestational age infants in women with low prepregnancy body mass index. Journal of Obstetrics and Gynaecology Research 36:3, 506-512
    CrossRef

  67. 67

    Marc Q. Mazzuca, Mary E. Wlodek, Nicoleta M. Dragomir, Helena C. Parkington, Marianne Tare. (2010) Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. The Journal of Physiology 588:11, 1997-2010
    CrossRef

  68. 68

    Paul A.O.M. De Reu, Herman P. Oosterbaan, Luc J.M. Smits, Jan G. Nijhuis. (2010) Avoidable mortality in small-for-gestational-age children in the Netherlands. Journal of Perinatal Medicine 38:3, 311-318
    CrossRef

  69. 69

    Vanessa Laibl Rogers, Jeanne S. Sheffield, Scott W. Roberts, Donald D. McIntire, James P. Luby, Sylvia Trevino, George D. Wendel. (2010) Presentation of Seasonal Influenza A in Pregnancy. Obstetrics & Gynecology 115:5, 924-929
    CrossRef

  70. 70

    H. C. Lee, P. Ramachandran, A. Madan. (2010) Morbidity Risk at Birth for Asian Indian Small for Gestational Age Infants. American Journal of Public Health 100:5, 820-822
    CrossRef

  71. 71

    H Xu, F Simonet, Z-C Luo. (2010) Optimal birth weight percentile cut-offs in defining small- or large-for-gestational-age. Acta Paediatrica 99:4, 550-555
    CrossRef

  72. 72

    G. Frederiek Estourgie-van Burk, Meike Bartels, Dorret I. Boomsma, Henriette A. Delemarre-van de Waal. (2010) Body Size of Twins Compared with Siblings and the General Population: From Birth to Late Adolescence. The Journal of Pediatrics 156:4, 586-591
    CrossRef

  73. 73

    J. M. Cohen, J. A. Hutcheon, M. S. Kramer, K. S. Joseph, H. Abenhaim, R. W. Platt. (2010) Influence of ultrasound-to-delivery interval and maternal-fetal characteristics on validity of estimated fetal weight. Ultrasound in Obstetrics and Gynecology 35:4, 434-441
    CrossRef

  74. 74

    Jennifer A. Hutcheon, Grace M. Egeland, Lucie Morin, Sara J. Meltzer, Geir Jacobsen, Robert W. Platt. (2010) The predictive ability of conditional fetal growth percentiles. Paediatric and Perinatal Epidemiology 24:2, 131-139
    CrossRef

  75. 75

    Yinguo Zhang, Ning Li, Zhuo Yang. (2010) Perinatal food restriction impaired spatial learning and memory behavior and decreased the density of nitric oxide synthase neurons in the hippocampus of adult male rat offspring. Toxicology Letters 193:2, 167-172
    CrossRef

  76. 76

    J. C. Dumoulin, J. A. Land, A. P. Van Montfoort, E. C. Nelissen, E. Coonen, J. G. Derhaag, I. L. Schreurs, G. A. Dunselman, A. D. Kester, J. P. Geraedts, J. L. Evers. (2010) Effect of in vitro culture of human embryos on birthweight of newborns. Human Reproduction 25:3, 605-612
    CrossRef

  77. 77

    A.S. Khashan, T.B. Henriksen, P.B. Mortensen, R. McNamee, F.P. McCarthy, M.G. Pedersen, L.C. Kenny. (2010) The impact of maternal celiac disease on birthweight and preterm birth: a Danish population-based cohort study. Human Reproduction 25:2, 528-534
    CrossRef

  78. 78

    Yan Zhong, Methodius Tuuli, Anthony O. Odibo. (2010) First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenatal Diagnosisn/a-n/a
    CrossRef

  79. 79

    Cristiane Ortigosa Rocha, Roberto Eduardo Bittar, Marcelo Zugaib. (2010) Neonatal Outcomes of Late-Preterm Birth Associated or Not with Intrauterine Growth Restriction. Obstetrics and Gynecology International 2010, 1-5
    CrossRef

  80. 80

    B. C. Swan, P. Murthi, G. Rajaraman, N. A. Pathirage, J. M. Said, V. Ignjatovic, P. T. Monagle, S. P. Brennecke. (2010) Decorin expression is decreased in human idiopathic fetal growth restriction. Reproduction, Fertility and Development 22:6, 949
    CrossRef

  81. 81

    Jodie M Dodd, Rory C Windrim, Inge L van Kamp, Jodie M Dodd. 2010. .
    CrossRef

  82. 82

    LIANQIANG CHE, THOMAS THYMANN, STINE B. BERING, ISABELLE LE HUËROU-LURON, ROMAIN DʼINCA, KEYING ZHANG, PER T. SANGILD. (2010) IUGR Does Not Predispose to Necrotizing Enterocolitis or Compromise Postnatal Intestinal Adaptation in Preterm Pigs. Pediatric Research 67:1, 54-59
    CrossRef

  83. 83

    Nathan S. Fox, Stephen T. Chasen. (2009) First trimester pregnancy associated plasma protein-A as a marker for poor pregnancy outcome in patients with early-onset fetal growth restriction. Prenatal Diagnosis 29:13, 1244-1248
    CrossRef

  84. 84

    Sengwee Toh, Allen A. Mitchell, Carol Louik, Martha M. Werler, Christina D. Chambers, Sonia Hernández-Díaz. (2009) Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction. Journal of Clinical Psychopharmacology 29:6, 555-560
    CrossRef

  85. 85

    Roy M. Nilsen, Stein Emil Vollset, Håkon K. Gjessing, Rolv Skjaerven, Kari K. Melve, Patricia Schreuder, Elin R. Alsaker, Kjell Haug, Anne Kjersti Daltveit, Per Magnus. (2009) Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatric and Perinatal Epidemiology 23:6, 597-608
    CrossRef

  86. 86

    Minoru Mitani, Yoshio Matsuda, Yasuo Makino, Yoshika Akizawa, Hiroaki Ohta. (2009) Clinical features of fetal growth restriction complicated later by preeclampsia. Journal of Obstetrics and Gynaecology Research 35:5, 882-887
    CrossRef

  87. 87

    Cande V. Ananth, Anthony M. Vintzileos. (2009) Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Human Development 85:10, 653-658
    CrossRef

  88. 88

    Husn H. Frayha, Avedis Kalloghlian. (2009) Gram-specific quantitative polymerase chain reaction for diagnosis of neonatal sepsis: Implications for clinical practice*. Critical Care Medicine 37:8, 2487-2488
    CrossRef

  89. 89

    Patricia M. Dietz, William M. Callaghan, Ruben Smith, Andrea J. Sharma. (2009) Low pregnancy weight gain and small for gestational age: a comparison of the association using 3 different measures of small for gestational age. American Journal of Obstetrics and Gynecology 201:1, 53.e1-53.e7
    CrossRef

  90. 90

    Winnie W. I. Pang, Michelle H. Y. Tsui, Daljit Sahota, Tak Y. Leung, Tze K. Lau, Y. M. Dennis Lo, Rossa W. K. Chiu. (2009) A strategy for identifying circulating placental RNA markers for fetal growth assessment. Prenatal Diagnosis 29:5, 495-504
    CrossRef

  91. 91

    Mohamed Al-Shahat Nezar, Azza Mohammad Abd El-Baky, Othman Al-Said Soliman, Hesham Al-Said Abdel-Hady, Ayman Mohammad Hammad, Mohammad Saleh Al-Haggar. (2009) Endothelin-1 and leptin as markers of intrauterine growth restriction. The Indian Journal of Pediatrics 76:5, 485-488
    CrossRef

  92. 92

    Johann Cailhol, Gonzague Jourdain, Sophie Le Coeur, Patrinee Traisathit, Kamol Boonrod, Sinart Prommas, Chaiwat Putiyanun, Annop Kanjanasing, Marc Lallemant. (2009) Association of Low CD4 Cell Count and Intrauterine Growth Retardation in Thailand. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:4, 409-413
    CrossRef

  93. 93

    Suneet P. Chauhan, Lata M. Gupta, Nancy W. Hendrix, Vincenzo Berghella. (2009) Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines. American Journal of Obstetrics and Gynecology 200:4, 409.e1-409.e6
    CrossRef

  94. 94

    Kevin C. Worley, Jodi S. Dashe, Robert G. Barber, Stephen M. Megison, Donald D. McIntire, Diane M. Twickler. (2009) Fetal magnetic resonance imaging in isolated diaphragmatic hernia: volume of herniated liver and neonatal outcome. American Journal of Obstetrics and Gynecology 200:3, 318.e1-318.e6
    CrossRef

  95. 95

    Gary Chan. 2009. Pregnancy. .
    CrossRef

  96. 96

    Keiichiro YONEYAMA, Aiko KIMURA, Mari KOGO, Yuji KIUCHI, Taro MORIMOTO, Takashi OKAI. (2009) Clinical predictive factors for preterm birth in women with threatened preterm labour or preterm premature ruptured membranes?. Australian and New Zealand Journal of Obstetrics and Gynaecology 49:1, 16-21
    CrossRef

  97. 97

    Corine M. Koopmans, Judith Blaauw, Maria G. van Pampus, Gerhard Rakhorst, Jan G. Aarnoudse. (2009) Abnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restriction. American Journal of Obstetrics and Gynecology 200:1, 66.e1-66.e6
    CrossRef

  98. 98

    Paula Hedley, Kasper Pihl, Lone Krebs, Torben Larsen, Michael Christiansen. (2009) Leptin in first trimester pregnancy serum: no reduction associated with small-for-gestational-age infants. Reproductive BioMedicine Online 18:6, 832-837
    CrossRef

  99. 99

    Kasper Pihl, Torben Larsen, Lone Krebs, Michael Christiansen. (2008) First trimester maternal serum PAPP-A, β-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenatal Diagnosis 28:12, 1131-1135
    CrossRef

  100. 100

    Anna Maria Marconi, Stefania Ronzoni, Patrizia Bozzetti, Simona Vailati, Alberto Morabito, Frederick C. Battaglia. (2008) Comparison of Fetal and Neonatal Growth Curves in Detecting Growth Restriction. Obstetrics & Gynecology 112:6, 1227-1234
    CrossRef

  101. 101

    M Mohsin, B Jalaludin. (2008) Influence of previous pregnancy outcomes and continued smoking on subsequent pregnancy outcomes: an exploratory study in Australia. BJOG: An International Journal of Obstetrics & Gynaecology 115:11, 1428-1435
    CrossRef

  102. 102

    SK Akram, M Akram, ZA Bhutta, O Soder. (2008) Human placental IGF-I and IGF-II expression: correlating maternal and infant anthropometric variables and micronutrients at birth in the Pakistani population. Acta Paediatrica 97:10, 1443-1448
    CrossRef

  103. 103

    Irene Stafford, Jennifer Hernandez, Vanessa Laibl, Jeanne Sheffield, Scott Roberts, George Wendel. (2008) Community-Acquired Methicillin-Resistant Staphylococcus aureus Among Patients With Puerperal Mastitis Requiring Hospitalization. Obstetrics & Gynecology 112:3, 533-537
    CrossRef

  104. 104

    JASON PICCONI, GIANCARLO MARI. (2008) CLASSIFICATION AND MANAGEMENT OF GROWTH RESTRICTED FETUSES. Fetal and Maternal Medicine Review 19:03,
    CrossRef

  105. 105

    N. G. Pedersen, K. R. Wøjdemann, T. Scheike, A. Tabor. (2008) Fetal growth between the first and second trimesters and the risk of adverse pregnancy outcome. Ultrasound in Obstetrics and Gynecology 32:2, 147-154
    CrossRef

  106. 106

    N. S. Fox, M. Huang, S. T. Chasen. (2008) Second‐trimester fetal growth and the risk of poor obstetric and neonatal outcomes. Ultrasound in Obstetrics and Gynecology 32:1, 61-65
    CrossRef

  107. 107

    Adam Rosenberg. (2008) The IUGR Newborn. Seminars in Perinatology 32:3, 219-224
    CrossRef

  108. 108

    Suzanne E. Peterson, Hyagriv N. Simhan. (2008) First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. American Journal of Obstetrics and Gynecology 198:5, e43-e45
    CrossRef

  109. 109

    Radek Bukowski, Tatsuo Uchida, Gordon C. S. Smith, Fergal D. Malone, Robert H. Ball, David A. Nyberg, Christine H. Comstock, Gary D. V. Hankins, Richard L. Berkowitz, Susan J. Gross, Lorraine Dugoff, Sabrina D. Craigo, Ilan E. Timor, Stephen R. Carr, Honor M. Wolfe, Mary E. D’Alton. (2008) Individualized Norms of Optimal Fetal Growth. Obstetrics & Gynecology 111:5, 1065-1076
    CrossRef

  110. 110

    J. Seth Hawkins, Julie Y. Lo, Brian M. Casey, Donald D. McIntire, Kenneth J. Leveno. (2008) Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis. American Journal of Obstetrics and Gynecology 198:3, 287.e1-287.e6
    CrossRef

  111. 111

    Gustavo F. Gonzales, Vilma Tapia, Carlos E. Carrillo. (2008) Stillbirth rates in Peruvian populations at high altitude. International Journal of Gynecology & Obstetrics 100:3, 221-227
    CrossRef

  112. 112

    R M Adkins, J Krushkal, C K Klauser, E F Magann, J C Morrison, G Somes. (2008) Association between small for gestational age and paternally inherited 5′ insulin haplotypes. International Journal of Obesity 32:2, 372-380
    CrossRef

  113. 113

    Lisa Hui, Daniel Challis. (2008) Diagnosis and management of fetal growth restriction: the role of fetal therapy. Best Practice & Research Clinical Obstetrics & Gynaecology 22:1, 139-158
    CrossRef

  114. 114

    Munish Gupta. 2008. Intrauterine Growth Restriction. , 77-83.
    CrossRef

  115. 115

    N. Özbeka, F.B. Ataçb,, H. Verdib, S. Çetintaşa, B. Gürakan, A. Haberald. (2008) Relationship between small-for-gestational age births and maternal thrombophilic mutations. Thrombosis Research 122:2, 175-178
    CrossRef

  116. 116

    Barbara Vasapollo, Gian Paolo Novelli, Herbert Valensise. (2008) Fetal growth restriction and maternal cardiac function. Expert Review of Obstetrics & Gynecology 3:1, 119-127
    CrossRef

  117. 117

    Donald D. McIntire, Kenneth J. Leveno. (2008) Neonatal Mortality and Morbidity Rates in Late Preterm Births Compared With Births at Term. Obstetrics & Gynecology 111:1, 35-41
    CrossRef

  118. 118

    Laura G. Greer, Scott W. Roberts, Jeanne S. Sheffield, Vanessa L. Rogers, James B. Hill, Donald D. Mcintire, George D. Wendel. (2008) Ampicillin Resistance and Outcome Differences in Acute Antepartum Pyelonephritis. Infectious Diseases in Obstetrics & Gynecology 2008, 1-5
    CrossRef

  119. 119

    G. Crombach, K. Vetter. (2007) Intrauterine Wachstumsrestriktion. Der Gynäkologe 40:12, 983-999
    CrossRef

  120. 120

    G. Crombach. (2007) Intrauterine Wachstumsrestriktion. Der Gynäkologe 40:11, 891-902
    CrossRef

  121. 121

    Jodie M Dodd, John Kingdom, Anne McLeod, Rory C Windrim, Jodie M Dodd. 2007. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. .
    CrossRef

  122. 122

    Patricia C. Santiago-Munoz, Donald D. McIntire, Robert G. Barber, Stephen M. Megison, Diane M. Twickler, Jodi S. Dashe. (2007) Outcomes of Pregnancies With Fetal Gastroschisis. Obstetrics & Gynecology 110:3, 663-668
    CrossRef

  123. 123

    Megan L. Wier, Michelle Pearl, Martin Kharrazi. (2007) Gestational age estimation on United States livebirth certificates: a historical overview. Paediatric and Perinatal Epidemiology 21:s2, 4-12
    CrossRef

  124. 124

    Inderpal Singh Kochar, Khalid Hussain. (2007) From hyperinsulinaemic hypoglycaemia to ketotic hypoglycaemia: the range of glucose abnormalities in patients born with intrauterine growth retardation. European Journal of Pediatrics 166:10, 1003-1007
    CrossRef

  125. 125

    RONALD M. ADKINS, JOHN N. FAIN, JULIA KRUSHKAL, CHAD K. KLAUSER, EVERETT F. MAGANN, JOHN C. MORRISON. (2007) Association Between Paternally Inherited Haplotypes Upstream of the Insulin Gene and Umbilical Cord IGF-II Levels. Pediatric Research PAP,
    CrossRef

  126. 126

    Juan M. Gonzalez, David M. Stamilio, Serdar Ural, George A. Macones, Anthony O. Odibo. (2007) Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction. American Journal of Obstetrics and Gynecology 196:5, e48-e51
    CrossRef

  127. 127

    Deepa Sirsi, Joseph E Safdieh. (2007) The safety of levetiracetam. Expert Opinion on Drug Safety 6:3, 241-250
    CrossRef

  128. 128

    Brian M. Casey, Jodi S. Dashe, Catherine Y. Spong, Donald D. McIntire, Kenneth J. Leveno, Gary F. Cunningham. (2007) Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy. Obstetrics & Gynecology 109:5, 1129-1135
    CrossRef

  129. 129

    Bassam Haddad, Gilles Kayem, Stephanie Deis, Baha M. Sibai. (2007) Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?. American Journal of Obstetrics and Gynecology 196:3, 237.e1-237.e5
    CrossRef

  130. 130

    Marij Gielen, Patrick J. Lindsey, Catherine Derom, Ruth J.F. Loos, Robert Derom, Jan G. Nijhuis, Robert Vlietinck. (2007) Twin Birth Weight Standards. Neonatology 92:3, 164-173
    CrossRef

  131. 131

    Vanessa R. Laibl, Jeanne S. Sheffield, Scott Roberts, Donald D. McIntire, George D. Wendel. (2006) Recurrence of Clinical Chorioamnionitis in Subsequent Pregnancies. Obstetrics & Gynecology 108:6, 1493-1497
    CrossRef

  132. 132

    Sheree L. Boulet, Greg R. Alexander, Hamisu M. Salihu, Russell S. Kirby, Waldemar A. Carlo. (2006) Fetal growth risk curves: Defining levels of fetal growth restriction by neonatal death risk. American Journal of Obstetrics and Gynecology 195:6, 1571-1577
    CrossRef

  133. 133

    A. Copil, D. Yeste, R. Teixidó, J. Maciá, S. Santana, J. Almar, N. Tokashiki, C. Abellán, A. Carrascosa. (2006) Patrones antropométricos de los recién nacidos a término de grupos étnicos de raza no caucásica procedentes de África subsahariana, Marruecos y Sudamérica nacidos en Cataluña. Anales de Pediatría 65:5, 454-460
    CrossRef

  134. 134

    Renée Larocque, Martin Casapia, Eduardo Gotuzzo, J. Dick MacLean, Julio C. Soto, Elham Rahme, Theresa W. Gyorkos. (2006) A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Tropical Medicine and International Health 11:10, 1485-1495
    CrossRef

  135. 135

    E. Papadopoulou, S. Sifakis, E. Giahnakis, Y. Fragouli, N. Karkavitsas, E. Koumantakis, M. Kalmanti. (2006) Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Hormone & IGF Research 16:5-6, 290-296
    CrossRef

  136. 136

    Naomi E. Stotland, Yvonne W. Cheng, Linda M. Hopkins, Aaron B. Caughey. (2006) Gestational Weight Gain and Adverse Neonatal Outcome Among Term Infants. Obstetrics & Gynecology 108:3, Part 1, 635-643
    CrossRef

  137. 137

    Angelo Cagnacci, Francesco S. Pansini, Alberto Bacchi-Modena, Annibale Volpe. (2006) The relation of season of birth to severity of menopausal symptoms. Menopause 13:4, 700-705
    CrossRef

  138. 138

    Eugenia K. Pallotto, Howard W. Kilbride. (2006) Perinatal Outcome and Later Implications of Intrauterine Growth Restriction. Clinical Obstetrics and Gynecology 49:2, 257-269
    CrossRef

  139. 139

    Suneet P. Chauhan, Everett F. Magann. (2006) Screening for Fetal Growth Restriction. Clinical Obstetrics and Gynecology 49:2, 284-294
    CrossRef

  140. 140

    Kristine Y. Lain, Patrick M. Catalano. (2006) Factors That Affect Maternal Insulin Resistance and Modify Fetal Growth and Body Composition. Metabolic Syndrome and Related Disorders 4:2, 91-100
    CrossRef

  141. 141

    Peter Van Eerden, Xiao-Xuan Wu, Cynthia Chazotte, Jacob H. Rand. (2006) Annexin A5 levels in midtrimester amniotic fluid: Association with intrauterine growth restriction. American Journal of Obstetrics and Gynecology 194:5, 1371-1376
    CrossRef

  142. 142

    Larry G. Thaete, Mark G. Neerhof. (2006) Endothelin and platelet-activating factor: Significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. American Journal of Obstetrics and Gynecology 194:5, 1377-1383
    CrossRef

  143. 143

    Thomas A. Farley, Karen Mason, Janet Rice, Joanna D. Habel, Richard Scribner, Deborah A. Cohen. (2006) The relationship between the neighbourhood environment and adverse birth outcomes. Paediatric and Perinatal Epidemiology 20:3, 188-200
    CrossRef

  144. 144

    Jennifer H. Tang, Jeanne S. Sheffield, Julie Grimes, Barbara McElwee, Scott W. Roberts, Vanessa Laibl, Donald D. McIntire, George D. Wendel. (2006) Effect of Protease Inhibitor Therapy on Glucose Intolerance in Pregnancy. Obstetrics & Gynecology 107:5, 1115-1119
    CrossRef

  145. 145

    Francesca Dominici, Scott L. Zeger, Giovanni Parmigiani, Joanne Katz, Parul Christian. (2006) Estimating percentile-specific treatment effects in counterfactual models: a case-study of micronutrient supplementation, birth weight and infant mortality. Journal of the Royal Statistical Society: Series C (Applied Statistics) 55:2, 261-280
    CrossRef

  146. 146

    Q. Yang. (2006) Associations of Maternal Age- and Parity-Related Factors With Trends in Low-Birthweight Rates: United States, 1980 Through 2000. American Journal of Public Health 96:5, 856-861
    CrossRef

  147. 147

    L Cordero, A Franco, S D Joy. (2006) Monochorionic monoamniotic twins: neonatal outcome. Journal of Perinatology 26:3, 170-175
    CrossRef

  148. 148

    William A. Engle. (2006) A Recommendation for the Definition of “Late Preterm” (Near-Term) and the Birth Weight–Gestational Age Classification System. Seminars in Perinatology 30:1, 2-7
    CrossRef

  149. 149

    Brian M. Casey, Jodi S. Dashe, C Edward Wells, Donald D. McIntire, Kenneth J. Leveno, F Gary Cunningham. (2006) Subclinical Hyperthyroidism and Pregnancy Outcomes. Obstetrics & Gynecology 107:2, Part 1, 337-341
    CrossRef

  150. 150

    Clare Tower, Sally Chappell, Meera Acharya, Richard Crane, Stephanie Szolin, Lyneth Symonds, Helen Chevins, Noor Kalsheker, Philip Baker, Linda Morgan. (2006) Altered transmission of maternal angiotensin II receptor haplotypes in fetal growth restriction. Human Mutation 27:2, 138-144
    CrossRef

  151. 151

    S. Abu-Amero, D. Monk, S. Apostolidou, P. Stanier, G. Moore. (2006) Imprinted genes and their role in human fetal growth. Cytogenetic and Genome Research 113:1-4, 262-270
    CrossRef

  152. 152

    A. Dua, C. Schram. (2006) An investigation into the applicability of customised charts for the assessment of fetal growth in antenatal population at Blackburn, Lancashire, UK. Journal of Obstetrics & Gynaecology 26:5, 411-413
    CrossRef

  153. 153

    Angelo Cagnacci, Serenella Arangino, Simona Caretto, Vincenzo Mazza, Annibale Volpe. (2006) Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation. European Journal of Obstetrics & Gynecology and Reproductive Biology 124:1, 53-57
    CrossRef

  154. 154

    Suneet P. Chauhan, Jill Cole, Maureen Sanderson, Everett F. Magann, James A. Scardo. (2006) Suspicion of intrauterine growth restriction: Use of abdominal circumference alone or estimated fetal weight below 10%. Journal of Maternal-Fetal and Neonatal Medicine 19:9, 557-562
    CrossRef

  155. 155

    T. A. Mills, M. Wareing, G. J. Bugg, S. L. Greenwood, P. N. Baker. (2005) Chorionic plate artery function and Doppler indices in normal pregnancy and intrauterine growth restriction. European Journal of Clinical Investigation 35:12, 758-764
    CrossRef

  156. 156

    Leandro Cordero, Albert Franco, Saju D Joy, Richard W O'Shaughnessy. (2005) Monochorionic Diamniotic Infants Without Twin-to-Twin Transfusion Syndrome. Journal of Perinatology 25:12, 753-758
    CrossRef

  157. 157

    DIEGO GAZZOLO, PASQUALE FLORIO, SABINA CIOTTI, EMANUELA MARINONI, ROMOLO DI IORIO, MATTEO BRUSCHETTINI, RENATA SACCHI, GIOVANNI SERRA, MARIO LITUANIA, FABRIZIO MICHETTI. (2005) S100B Protein in Urine of Preterm Newborns with Ominous Outcome. Pediatric Research 58:6, 1170-1174
    CrossRef

  158. 158

    S Fang. (2005) Management of preterm infants with intrauterine growth restriction. Early Human Development 81:11, 889-900
    CrossRef

  159. 159

    Jodi S. Dashe, Brian M. Casey, C Edward Wells, Donald D. McIntire, E William Byrd, Kenneth J. Leveno, F Gary Cunningham. (2005) Thyroid-Stimulating Hormone in Singleton and Twin Pregnancy: Importance of Gestational Age–Specific Reference Ranges. Obstetrics & Gynecology 106:4, 753-757
    CrossRef

  160. 160

    Vanessa R. Laibl, Jeanne S. Sheffield, Scott Roberts, Donald D. McIntire, Sylvia Trevino, George D. Wendel. (2005) Clinical Presentation of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Pregnancy. Obstetrics & Gynecology 106:3, 461-465
    CrossRef

  161. 161

    Nicole P. Yost, Steven L. Bloom, Donald D. McIntire, Kenneth J. Leveno. (2005) Hospitalization for Women With Arrested Preterm Labor. Obstetrics & Gynecology 106:1, 14-18
    CrossRef

  162. 162

    Pierre-Yves Ancel, Stéphane Marret, Béatrice Larroque, Catherine Arnaud, Véronique Zupan-Simunek, Marcel Voyer, Jean-Christophe Rozé, Jacqueline Matis, Antoine Burguet, Bernard Ledésert, Monique André, Véronique Pierrat, Monique Kaminski, the Epipage Study Group. (2005) Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. American Journal of Obstetrics and Gynecology 193:1, 178-184
    CrossRef

  163. 163

    Daniel M.T. Fessler, C. David Navarrete, William Hopkins, M. Kay Izard. (2005) Examining the terminal investment hypothesis in humans and chimpanzees: Associations among maternal age, parity, and birth weight. American Journal of Physical Anthropology 127:1, 95-104
    CrossRef

  164. 164

    Klara ten Berg, E. Bettina Samrén, A. Carla van Oppen, Martijn Engelsman, Dick Lindhout. (2005) Levetiracetam use and pregnancy outcome. Reproductive Toxicology 20:1, 175-178
    CrossRef

  165. 165

    Sandra Dieni, Sandra Rees. (2005) BDNF and TrkB protein expression is altered in the fetal hippocampus but not cerebellum after chronic prenatal compromise. Experimental Neurology 192:2, 265-273
    CrossRef

  166. 166

    William W. K. TO, Alice M. Y. CHAN, Ka-Ming MOK. (2005) Use of umbilical-cerebral Doppler ratios in predicting fetal growth restriction in near-term fetuses. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45:2, 130-136
    CrossRef

  167. 167

    Roberta M. Shear, Denyse Rinfret, Line Leduc. (2005) Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?. American Journal of Obstetrics and Gynecology 192:4, 1119-1125
    CrossRef

  168. 168

    Heather E.A. Howley, Mark Walker, Marc A. Rodger. (2005) A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. American Journal of Obstetrics and Gynecology 192:3, 694-708
    CrossRef

  169. 169

    Brian M. Casey, Jodi S. Dashe, C Edward Wells, Donald D. McIntire, William Byrd, Kenneth J. Leveno, F Gary Cunningham. (2005) Subclinical Hypothyroidism and Pregnancy Outcomes. Obstetrics & Gynecology 105:2, 239-245
    CrossRef

  170. 170

    Bhavneet Bharti, Sahul Bharti. (2005) A review of the Apgar score indicated that contextualization was required within the contemporary perinatal and neonatal care framework in different settings. Journal of Clinical Epidemiology 58:2, 121-129
    CrossRef

  171. 171

    E Rieger-Fackeldey, A Schulze, F Pohlandt, R Schwarze, J Dinger, W Lindner. (2005) Short-term outcome in infants with a birthweight less than 501 grams. Acta Paediatrica 94:2, 211-216
    CrossRef

  172. 172

    Alma Martinez, Rebecca Simmons. 2005. Abnormalities of Fetal Growth. , 32-45.
    CrossRef

  173. 173

    E. Rieger-Fackeldey, A. Schulze, F. Pohlandt, R. Schwarze, J. Dinger, W. Lindner. (2005) Short-term outcome in infants with a birthweight less than 501 grams. Acta Paediatrica 94:2, 211
    CrossRef

  174. 174

    Deborah K. Steward, Debra K. Moser. (2004) Intrauterine growth retardation in full-term newborn infants with birth weights greater than 2,500 g. Research in Nursing & Health 27:6, 403-412
    CrossRef

  175. 175

    Sebastian Illanes, Peter Soothill. (2004) Management of fetal growth restriction. Seminars in Fetal and Neonatal Medicine 9:5, 395-401
    CrossRef

  176. 176

    Victor Y.H. Yu, Amit Upadhyay. (2004) Neonatal management of the growth-restricted infant. Seminars in Fetal and Neonatal Medicine 9:5, 403-409
    CrossRef

  177. 177

    Thomas J. Garite, Reese Clark, James A. Thorp. (2004) Intrauterine growth restriction increases morbidity and mortality among premature neonates. American Journal of Obstetrics and Gynecology 191:2, 481-487
    CrossRef

  178. 178

    E. Lindhoff-Last. (2004) Maternal thrombophilia and obstetric complications / Mütterliche Thrombophilie und geburtshilfliche Komplikationen. LaboratoriumsMedizin 28:1, 34-41
    CrossRef

  179. 179

    Stefania Tentoni, Paola Astolfi, Antonio Pasquale, Laura A. Zonta. (2004) Birthweight by gestational age in preterm babies according to a Gaussian mixture model. BJOG: An International Journal of Obstetrics and Gynaecology 111:1, 31-37
    CrossRef

  180. 180

    Avi Ben-Haroush, Yariv Yogev, Hagit Glickman, Boris Kaplan, Moshe Hod, Jacob Bar. (2004) Mode of delivery in pregnancies with suspected fetal growth restriction following induction of labor with vaginal prostaglandin E2. Acta Obstetricia et Gynecologica Scandinavica 83:1, 52-57
    CrossRef

  181. 181

    Elke H Roland, Alan Hill. (2003) Germinal matrix–intraventricular hemorrhage in the premature newborn: management and outcome. Neurologic Clinics 21:4, 833-851
    CrossRef

  182. 182

    Y. Friedlander, O. Paltiel, L. Deutsch, A. Knaanie, S. Massalha, E. Tiram, S. Harlap. (2003) Birthweight and relationship with infant, child and adult mortality in the Jerusalem perinatal study. Paediatric and Perinatal Epidemiology 17:4, 398-406
    CrossRef

  183. 183

    Johnny S Younis, Arnon Samueloff. (2003) Gestational vascular complications. Best Practice & Research Clinical Haematology 16:2, 135-151
    CrossRef

  184. 184

    M. PAMELA GRIFFIN, T. MICHAEL O???SHEA, ERIC A. BISSONETTE, FRANK E. HARRELL, DOUGLAS E. LAKE, AND, J. RANDALL MOORMAN. (2003) Abnormal Heart Rate Characteristics Preceding Neonatal Sepsis and Sepsis-Like Illness. Pediatric Research 53:6, 920-926
    CrossRef

  185. 185

    Infante-Rivard, Claire, Rivard, Georges-Etienne, Yotov, Wagner V., Génin, Emmanuelle, Guiguet, Marguerite, Weinberg, Clarice, Gauthier, Robert, Feoli-Fonseca, Juan Carlos, . (2002) Absence of Association of Thrombophilia Polymorphisms with Intrauterine Growth Restriction. New England Journal of Medicine 347:1, 19-25
    Full Text

  186. 186

    Lilith M. Tatham, Frank J. Bove, Wendy E. Kaye, Robert F. Spengler. (2002) Population exposures to I-131 releases from Hanford Nuclear Reservation and preterm birth, infant mortality, and fetal deaths. International Journal of Hygiene and Environmental Health 205:1-2, 41-48
    CrossRef

  187. 187

    Paola Astolfi, Laura A. Zonta. (2002) Delayed maternity and risk at delivery. Paediatric and Perinatal Epidemiology 16:1, 67-72
    CrossRef

  188. 188

    D K Steward. (2001) Biological vulnerability in infants with failure to thrive: the association with birthweight. Child: Care, Health and Development 27:6, 555-567
    CrossRef

  189. 189

    Bernadette Mazurek Melnyk, Linda Alpert-Gillis, Nancy Fischbeck Feinstein, Eileen Fairbanks, Jaclyn Schultz-Czarniak, Diane Hust, Laura Sherman, Christine LeMoine, Zendi Moldenhauer, Leigh Small, Nancee Bender, Robert A. Sinkin, MD. (2001) Improving cognitive development of low-birth-weight premature infants with the COPE program: A pilot study of the benefit of early NICU intervention with mothers. Research in Nursing & Health 24:5, 373-389
    CrossRef

  190. 190

    Britt Clausson, Jason Gardosi, Andre Francis, Sven Cnattingius. (2001) Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG: An International Journal of Obstetrics and Gynaecology 108:8, 830-834
    CrossRef

  191. 191

    T Chard. (2001) The risk of neonatal death in relation to birth weight and maternal hypertensive disease in infants born at 24–32 weeks. European Journal of Obstetrics & Gynecology and Reproductive Biology 95:1, 114-118
    CrossRef

  192. 192

    Meta Phoojaroenchanachai, Sutin Sriussadaporn, Thavatchai Peerapatdit, Sathit Vannasaeng, Wannee Nitiyanant, Vipa Boonnamsiri, Apichati Vichayanrat. (2001) Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clinical Endocrinology 54:3, 365-370
    CrossRef

  193. 193

    Leslie N. Sutton, Peter Sun, N. Scott Adzick. (2001) Fetal Neurosurgery. Neurosurgery 48:1, 124-144
    CrossRef

  194. 194

    Laura A. Magee. (2001) Treating Hypertension in Women of Child-Bearing Age and during Pregnancy. Drug Safety 24:6, 457-474
    CrossRef

  195. 195

    B Clausson. (2000) Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. British Journal of Obstetrics and Gynaecology 108:8, 830-834
    CrossRef

  196. 196

    Adriana Schüler Cavalli, Toyoho Tanaka. (2000) Maternal leisure-time physical activities are not determinant risk factors of low birthweight babies: A cross-sectional study of 1,714 pregnant women. Environmental Health and Preventive Medicine 5:2, 72-80
    CrossRef

  197. 197

    Michael Gleiβner, Gerhard Jorch, Stefan Avenarius. (2000) Risk factors for intraventricular hemorrhage in a birth cohort of 3721 premature infants. Journal of Perinatal Medicine 28:2, 104-110
    CrossRef

  198. 198

    Diego Botero, Fima Lifshitz. (1999) Intrauterine growth retardation and long-term effects on growth. Current Opinion in Pediatrics 11:4, 340-347
    CrossRef